Compare Recursion Pharmaceuticals Inc (RXRX) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs State Street Real Estate Select Sector SPDR ETF — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while State Street Real Estate Select Sector SPDR ETF trades at $45.34. The key difference: State Street Real Estate Select Sector SPDR ETF is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| RXRX | XLRE | |
|---|---|---|
Market Cap | $1.53B | — |
Sector | Health | Sector/Thematic |
52-Week High | $6.79 | $45.46 |
52-Week Low | $2.84 | $40.01 |
Enterprise Value | $946.50M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLRE, the Real Estate Select Sector SPDR ETF, trades at $45.23 with a slight 0.42% decline. Technical indicators show a bullish trend with strong moving average support, though RSI suggests potential overbought conditions. The ETF has gained 11% year-to-date, benefiting from REIT sector recovery despite interest rate volatility. Recent news highlights XLRE's low 0.08% expense ratio advantage and steady dividend yield around 3.4%.
Outlook remains cautiously optimistic as REIT fundamentals improve with stable NOI growth and potential M&A activity. Key risks include interest rate sensitivity and inflation pressures. Wall Street sentiment is positive with the sector showing resilience amid broader market volatility, though investors should monitor Fed policy shifts that could impact real estate valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About State Street Real Estate Select Sector SPDR ETF
XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →
